Log in to save to my catalogue

Enhanced Oral Bioavailability of Epalrestat SBE 7 -β-CD Complex Loaded Chitosan Nanoparticles: Prepa...

Enhanced Oral Bioavailability of Epalrestat SBE 7 -β-CD Complex Loaded Chitosan Nanoparticles: Prepa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_35002232

Enhanced Oral Bioavailability of Epalrestat SBE 7 -β-CD Complex Loaded Chitosan Nanoparticles: Preparation, Characterization and in-vivo Pharmacokinetic Evaluation

About this item

Full title

Enhanced Oral Bioavailability of Epalrestat SBE 7 -β-CD Complex Loaded Chitosan Nanoparticles: Preparation, Characterization and in-vivo Pharmacokinetic Evaluation

Publisher

New Zealand

Journal title

International journal of nanomedicine, 2021, Vol.16, p.8353

Language

English

Formats

Publication information

Publisher

New Zealand

More information

Scope and Contents

Contents

Epalrestat (EPL) is a carboxylic acid derivative with poor aqueous solubility and its pharmacokinetic features are not fully defined.
Current research aimed to fabricate inclusion complexation of EPL with SBE
β-CD (IC) and EPL/SBE
β-CD CS NPs (NP).
EPL was complexed with SBE
β-CD using the co-precipitation method, and the prepared co...

Alternative Titles

Full title

Enhanced Oral Bioavailability of Epalrestat SBE 7 -β-CD Complex Loaded Chitosan Nanoparticles: Preparation, Characterization and in-vivo Pharmacokinetic Evaluation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_35002232

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_35002232

Other Identifiers

E-ISSN

1178-2013

DOI

10.2147/IJN.S339857

How to access this item